The United States has penned an agreement with drug-maker Moderna Inc. to acquire 100 million doses of its potential COVID-19 vaccine, U.S. president Donald Trump said in a press conference on Tuesday. The U.S. has made several deals to acquire doses of potential COVID-19 vaccines in advance of their approval by regulators, part of its Operation Warp Speed program that aims to deliver a vaccine in the U.S. by the end of 2020.
Health
Coronavirus: Trump says U.S. inks agreement with Moderna for 100M doses of COVID-19 vaccine candidate
More Videos
-
Ozempic maker bringing weight-loss drug Wegovy to Canada
-
Health Matters: Newfoundland and Labrador work to hire, retain nurses through incentives
-
Toxic metals in vapes linked with major health problems in youth, study finds
-
Ozempic-makers’ weight-loss drug, Wegovy, coming soon to Canada
-
Weight-loss drug Wegovy available in Canada starting May 6
-
Health Matters: Caregiver report highlights need for help
You are viewing an Accelerated Mobile Webpage.
View Original Article